The Delhi High Court has allowed, sale and manufacture of Breast cancer drug Trastuzumab by Biocon Limited, an India based company, with certain restrictions.Justice Manmohan Singh, in a 227 page Order disposing of an interim application by Roche Products (India) Pvt Ltd., said that the Biocon can continue to sale and manufacture the drug, without calling their product as “bio similar”...
We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok